Sophie Kim
Clinical Trial Manager
Sophie Kim supports Clinical Operations, helping drive clinical trial execution. Sophie joined Imbria from Dragonfly Therapeutics, where she led day-to-day operations and supported oversight of two early-phase oncology studies.
Prior to Dragonfly, Sophie held research and discovery roles at Vesigen Therapeutics, Visterra Inc., and Dana-Farber Cancer Institute. She holds a BS in Biology from Boston College.